Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT-guided High Frequency Ranibizumab in AMD
NCT03393767Phase 4Completed
- Sponsor
- Vista Klinik
- Start
- Dec 2010
- Primary completion
- Oct 2016
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in age-related macular degeneration (AMD), sponsored by Vista Klinik. Started Dec 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT03393767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393767.